GNTA (GNTA) Stock Price & Analysis
GNTA (GNTA) rose 1.01% to USD 0.96 as of September 8, 2026 at 12:44 UTC, according to Nexqual real-time market data.
GNTA last closed at USD 0.96; the session ranged USD 0.94–0.99 on volume of 31,642 shares. Market capitalization is —, with a 52-week range of USD 0.55–10 (NCM). Source: Nexqual, September 8, 2026 at 12:44 UTC.
Key Statistics (as of September 8, 2026 at 12:44 UTC)
| Price | USD 0.96 |
|---|---|
| Change | ▲ 1.01% (up) |
| Previous Close | USD 0.96 |
| Open | USD 0.96 |
| Day Range | USD 0.94 – 0.99 |
| 52-Week Range | USD 0.55 – 10 |
| Volume | 31,642 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (GNTA)
Nexqual's technical model rates GNTA "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 12:44 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 26 (oversold) |
| vs SMA50 | Below (USD 1.38) |
| MACD | -0.12 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BIOM | Biomolecular Life Holdings, Inc. | USD 0.41 | ▼ 14.55% |
| CASIF | CASI Pharmaceuticals, Inc. | USD 0.15 | ▲ 7.14% |
| TGEN | Tecogen Inc. | USD 3.13 | ▲ 6.1% |
| NGEN | NervGen Pharma Corp. | USD 2.33 | ▲ 0% |
| OSCI | Osceola Gold, Inc. | USD 0.07 | ▲ 15% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 12:44 UTC. This page is informational and not investment advice.